Bruns CJ - Search Results

1

Genetically engineered stem cells for therapeutic gene delivery.

Conrad C, Gupta R, Mohan H, Niess H, Bruns CJ, Kopp R, von Luettichau I, Guba M, Heeschen C, Jauch KW, Huss R, Nelson PJ. Conrad C, et al. Among authors: bruns cj. Curr Gene Ther. 2007 Aug;7(4):249-60. doi: 10.2174/156652307781369119. Curr Gene Ther. 2007. PMID: 17969558 Review.

2

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK. Guba M, et al. Among authors: bruns cj. Nat Med. 2002 Feb;8(2):128-35. doi: 10.1038/nm0202-128. Nat Med. 2002. PMID: 11821896

3

Vascular endothelial growth factor in colorectal cancer.

Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Guba M, et al. Int J Colorectal Dis. 2004 Nov;19(6):510-7. doi: 10.1007/s00384-003-0576-y. Epub 2004 Mar 4. Int J Colorectal Dis. 2004. PMID: 14999511 Review.

4

Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.

Seeliger H, Guba M, Koehl GE, Doenecke A, Steinbauer M, Bruns CJ, Wagner C, Frank E, Jauch KW, Geissler EK. Seeliger H, et al. Among authors: bruns cj. Clin Cancer Res. 2004 Mar 1;10(5):1843-52. doi: 10.1158/1078-0432.ccr-1176-3. Clin Cancer Res. 2004. PMID: 15014039

5

Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer.

Bruns CJ, Koehl GE, Guba M, Yezhelyev M, Steinbauer M, Seeliger H, Schwend A, Hoehn A, Jauch KW, Geissler EK. Bruns CJ, et al. Clin Cancer Res. 2004 Mar 15;10(6):2109-19. doi: 10.1158/1078-0432.ccr-03-0502. Clin Cancer Res. 2004. PMID: 15041732

6

Vascular endothelial growth factor in esophageal cancer.

Kleespies A, Guba M, Jauch KW, Bruns CJ. Kleespies A, et al. Among authors: bruns cj. J Surg Oncol. 2004 Aug 1;87(2):95-104. doi: 10.1002/jso.20070. J Surg Oncol. 2004. PMID: 15282704 Review.

7

Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.

Yezhelyev MV, Koehl G, Guba M, Brabletz T, Jauch KW, Ryan A, Barge A, Green T, Fennell M, Bruns CJ. Yezhelyev MV, et al. Among authors: bruns cj. Clin Cancer Res. 2004 Dec 1;10(23):8028-36. doi: 10.1158/1078-0432.CCR-04-0621. Clin Cancer Res. 2004. PMID: 15585638

8

Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice.

Bruell D, Bruns CJ, Yezhelyev M, Huhn M, Müller J, Ischenko I, Fischer R, Finnern R, Jauch KW, Barth S. Bruell D, et al. Among authors: bruns cj. Int J Mol Med. 2005 Feb;15(2):305-13. Int J Mol Med. 2005. PMID: 15647848

9

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.

Guba M, Yezhelyev M, Eichhorn ME, Schmid G, Ischenko I, Papyan A, Graeb C, Seeliger H, Geissler EK, Jauch KW, Bruns CJ. Guba M, et al. Among authors: bruns cj. Blood. 2005 Jun 1;105(11):4463-9. doi: 10.1182/blood-2004-09-3540. Epub 2005 Jan 25. Blood. 2005. PMID: 15671443 Free article.

10

FTY720 inhibits tumor growth and angiogenesis.

Schmid G, Guba M, Papyan A, Ischenko I, Brückel M, Bruns CJ, Jauch KW, Graeb C. Schmid G, et al. Among authors: bruns cj. Transplant Proc. 2005 Jan-Feb;37(1):110-1. doi: 10.1016/j.transproceed.2004.12.278. Transplant Proc. 2005. PMID: 15808563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

652 results

Search Page

Filters